June 12, 2026 | 10:04
DKSH has entered a strategic distribution partnership with BridgeBio to support regulatory evaluation and potential patient access to a Transthyretin Stabilizer for ATTR cardiomyopathy in Australia, Singapore, South Korea, and Taiwan.